NM_021738.3:c.-200-1638C>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021738.3(SVIL):c.-200-1638C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_021738.3 intron
Scores
Clinical Significance
Conservation
Publications
- myofibrillar myopathy 10Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_021738.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SVIL | NM_021738.3 | MANE Select | c.-200-1638C>A | intron | N/A | NP_068506.2 | |||
| SVIL | NM_001323599.2 | c.-200-1638C>A | intron | N/A | NP_001310528.1 | ||||
| SVIL | NM_001323600.1 | c.-200-1638C>A | intron | N/A | NP_001310529.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SVIL | ENST00000355867.9 | TSL:1 MANE Select | c.-200-1638C>A | intron | N/A | ENSP00000348128.4 | |||
| SVIL | ENST00000375400.7 | TSL:1 | c.-200-1638C>A | intron | N/A | ENSP00000364549.3 | |||
| SVIL | ENST00000375398.6 | TSL:5 | c.-200-1638C>A | intron | N/A | ENSP00000364547.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at